In connection with the implementation of the project entitled ”Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, under contract no. 2022/ABM/06/00005-00 for co-financing of the Commercial Project as part of the Competition for the development of targeted or personalized medicine based on medicinal products based on nucleic acids and small molecular weight compounds, the Ordering Party is conducting market research regarding the costs of purchase and delivery of phosphoramidites.
In order to submit an offer, we ask you to read the announcement in the supply and to send us the completed offer form and the assortment-price form. (Excel)